John Vavricka
Förmögenhet: 771 026 $ per 2026-05-31
Förmögenhet: 771 026 $ per 2026-05-31
John F.
Vavricka was the founder of Iroko Pharmaceuticals LLC, founded in 2007, serving as President & Chief Executive Officer.
Mr. Vavricka was the founder of Biothea Pharma, Inc., founded in 2015, serving as Chief Executive Officer.
Mr. Vavricka is currently the Chief Commercial Officer at Atea Pharmaceuticals, Inc., starting in 2018.
Former positions include President & Chief Executive Officer at Iroko Pharmaceuticals, Inc., Chief Executive Officer at Iroko Holdings LLC, Vice President-Commercial Operations at Seqirus Vaccines Ltd. from 2003 to 2007, Vice President-Regional Sales at GlaxoSmithKline Pharmaceuticals Ltd. from 2001 to 2003, Vice President-Regional Sales at Smithkline Beecham Pharmaceuticals (India) Ltd. from 1987 to 1999, and Vice President-Commercial Operations at Novartis Vaccines & Diagnostics, Inc. Education includes an undergraduate degree from Northwestern University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-24 | 165 102 ( 0,21 % ) | 771 026 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Företagsledare/Principal | 2018-10-01 |
| Företag | Position | Slut |
|---|---|---|
Biothea Pharma, Inc.
Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Verkställande Direktör | 2021-06-01 |
Iroko Pharmaceuticals LLC
Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Verkställande Direktör | 2016-07-06 |
Seqirus Vaccines Ltd.
Seqirus Vaccines Ltd. BiotechnologyHealth Technology Manufactures vaccines | Företagsledare/Principal | - |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Företagsledare/Principal | - |
Smithkline Beecham Pharmaceuticals (India) Ltd.
Smithkline Beecham Pharmaceuticals (India) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Försäljning & Marknadsföring | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Seqirus Vaccines Ltd.
Seqirus Vaccines Ltd. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Iroko Pharmaceuticals, Inc.
Iroko Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
GlaxoSmithKline Pharmaceuticals Ltd.
GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Smithkline Beecham Pharmaceuticals (India) Ltd.
Smithkline Beecham Pharmaceuticals (India) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Health Technology |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Iroko Pharmaceuticals LLC
Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Iroko Holdings LLC
Iroko Holdings LLC Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in manufacturing and distributing pharmaceutical products | Health Technology |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån